Equities

Luye Pharma Group Ltd

Luye Pharma Group Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)3.02
  • Today's Change0.00 / 0.00%
  • Shares traded5.74m
  • 1 Year change-9.85%
  • Beta1.3623
Data delayed at least 15 minutes, as of Sep 20 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue6,1435,9825,200
OPERATING EXPENSES
Cost of revenue total1,9391,8411,803
Selling, general and admin. expenses, total2,7002,4032,271
Depreciation/amortization----4.99
Unusual expense(income)4.9114262
Other operating expenses, total(116)(36)2.42
Total operating expense4,7684,8414,876
Operating income1,3751,141324
Other, net------
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes700670(75)
Provision for income taxes1618670
Net income after taxes539583(145)
Minority interest(6.47)2210
Net income before extra. Items533605(134)
Total extraordinary items------
Net income533605(134)
Inc.avail. to common excl. extra. Items533605(134)
Inc.avail. to common incl. extra. Items533605(134)
EPS RECONCILIATION
Basic/primary weighted average shares3,7283,4813,445
Basic/primary eps excl. extra items0.140.17(0.04)
Basic/primary eps incl. extra items0.140.17(0.04)
Dilution adjustment------
Diluted weighted average shares3,7283,4813,445
Diluted eps excl. extra items0.140.17(0.04)
Diluted eps incl. extra items0.140.17(0.04)
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental675472399
SUPPLEMENTAL INCOME
Depreciation, supplemental378367343
Total special items4.9169262
NORMALISED INCOME
Normalized income before taxes705738188
Effect of special items on income taxes1.138.8792
Income tax excluding impact of special items16295162
Normalized income after tax54364326
Normalized income avail. to common53666536
Basic normalized EPS0.140.190.01
Diluted normalized EPS0.140.190.01
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.